Skip to main navigation
Skip to search
Skip to main content
Augusta University Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at Augusta University Research Profiles
Home
Profiles
Research Units
Scholarly Output
Projects
Datasets
Equipment
Activities
Press/Media
Prizes
Nanobubbles enhanced drug susceptibility of cancer cells using ultrasound
Maiko Suzuki
, K. Koshiyama
, F. Shinohara
, S. Mori
, M. Ono
, Y. Tomita
, T. Yano
, S. Fujikawa
, G. Vassaux
, T. Kodama
Oral Biology & Dx Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
23
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nanobubbles enhanced drug susceptibility of cancer cells using ultrasound'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Cells
100%
Ultrasound
100%
Drug Susceptibility
100%
Microbubbles
100%
Cytotoxicity
66%
Shock Waves
33%
Cavitation Bubble
33%
Duty Ratio
33%
Anticancer Drugs
16%
Lipids
16%
Cisplatin
16%
5-fluorouracil (5-FU)
16%
MTT Assay
16%
Albumin
16%
Plasmid DNA (pDNA)
16%
Membrane Permeability
16%
Lipid Bilayer
16%
Human Breast Adenocarcinoma
16%
MCF-7
16%
Carcinoma Cells
16%
Human Kidney
16%
Molecular Dynamics Simulation
16%
Rectal Carcinoma
16%
EMT6
16%
Ultrasonic Frequency
16%
Shock Wave Impulse
16%
Murine Mammary Carcinoma
16%
Colon 26
16%
Molecular Delivery
16%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Cytotoxicity
100%
Drug Sensitivity
100%
Shock Wave
75%
Lipid
25%
Colon
25%
Plasmid
25%
Cisplatin
25%
Anticancer
25%
Lipid Bilayer
25%
Membrane Permeability
25%
MTT Assay
25%
Albumin
25%
Immunology and Microbiology
Cancer Cell
100%
Cytotoxicity
100%
Drug Sensitivity
100%
Shock Wave
75%
Carcinoma Cell
25%
Colon
25%
Plasmid
25%
Membrane Permeability
25%
Rectum
25%
Albumin
25%
Lipid Bilayer
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Nanobubble
100%
Cytotoxicity
66%
Shock Wave
50%
Lipid
33%
Anticarcinogen
16%
Cisplatin
16%
Plasmid DNA
16%
Breast Carcinoma
16%
Breast Adenocarcinoma
16%
Albumin
16%
Rectum Carcinoma
16%